Data / Drug companies / Thiazide-like Diuretic
Thiazide-like Diuretic drugs: 7 drugs from 59 companies in the FDA NDC directory
Thiazide-like Diuretic is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 206 products in this class from 59 companies, covering 7 drugs by generic name. The main marketing category is generic drugs (ANDA), and the newest product started marketing on September 21, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 59Companies
- 206Products
- 7Drugs by generic name
Drugs in the Thiazide-like Diuretic class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Chlorthalidone | 105 | 42 |
| Metolazone | 62 | 22 |
| Indapamide | 17 | 10 |
| Atenolol and chlorthalidone | 15 | 9 |
| Telmisartan, amlodipine and indapamide | 3 | 1 |
| Atenolol and chlorthalidone tablet | 2 | 1 |
| Azilsartan kamedoxomil and chlorthalidone | 2 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Bryant Ranch Prepack | 14 | tablet; tablet, film coated | Generic drugs (ANDA) | October 23, 2024 |
| A-S Medication Solutions | 10 | tablet; tablet, film coated | Generic drugs (ANDA) | August 20, 2021 |
| Bryant Ranch Prepack | 10 | tablet; tablet, film coated | Generic drugs (ANDA) | May 12, 2025 |
| Bryant Ranch Prepack | 10 | tablet; tablet, film coated | Generic drugs (ANDA) | August 5, 2022 |
| Method Pharmaceuticals, LLC | 6 | tablet | Generic drugs (ANDA) | January 28, 2026 |
| Preferred Pharmaceuticals Inc. | 6 | tablet; tablet, film coated | Generic drugs (ANDA) | July 24, 2026 |
| Alembic Pharmaceuticals Inc. | 5 | tablet | Generic drugs (ANDA) | August 29, 2022 |
| Alembic Pharmaceuticals Limited | 5 | tablet | Generic drugs (ANDA) | August 29, 2022 |
| Aphena Pharma Solutions - Tennessee, LLC | 5 | tablet | Generic drugs (ANDA) | October 20, 2022 |
| Golden State Medical Supply, Inc. | 5 | tablet; tablet, film coated | Generic drugs (ANDA) | March 30, 2021 |
| Marlex Pharmaceuticals, Inc. | 5 | tablet | Generic drugs (ANDA) | December 1, 2022 |
| Mylan Pharmaceuticals Inc. | 5 | tablet | Generic drugs (ANDA) | October 19, 2004 |
| Northwind Health Company, LLC | 5 | tablet | Generic drugs (ANDA) | December 2, 2022 |
| Direct_Rx | 4 | tablet; tablet, film coated | Generic drugs (ANDA) | October 1, 2025 |
| Dr. Reddy's Laboratories Inc. | 4 | tablet | Generic drugs (ANDA) | October 20, 2022 |
| Ingenus Pharmaceuticals, LLC | 4 | tablet | Generic drugs (ANDA) | March 17, 2025 |
| Major Pharmaceuticals | 4 | tablet | Generic drugs (ANDA) | January 12, 2026 |
| NorthStar Rx LLC | 4 | tablet | Generic drugs (ANDA) | November 21, 2019 |
| Remedyrepack Inc. | 4 | tablet | Generic drugs (ANDA) | March 4, 2026 |
| Rising Pharma Holdings, Inc. | 4 | tablet | Generic drugs (ANDA) | October 23, 2024 |
| Unichem Pharmaceuticals (USA), Inc. | 4 | tablet | Generic drugs (ANDA) | November 25, 2020 |
| Zydus Lifesciences Limited | 4 | tablet | Generic drugs (ANDA) | May 15, 2019 |
| Aarkish Pharmaceuticals NJ Inc. | 3 | tablet | Generic drugs (ANDA) | August 15, 2023 |
| Advagen Pharma Ltd | 3 | tablet | Generic drugs (ANDA) | August 20, 2021 |
| American Health Packaging | 3 | tablet | Generic drugs (ANDA) | June 27, 2022 |
| Amici Pharma, Inc. | 3 | tablet | Generic drugs (ANDA) | May 15, 2021 |
| Azurity Pharmaceuticals, Inc. | 3 | tablet | New drug applications (NDA) | October 20, 2025 |
| Mylan Institutional Inc. | 3 | tablet | Generic drugs (ANDA) | April 15, 2005 |
| Safecor Health, LLC | 3 | tablet | Generic drugs (ANDA) | March 26, 2026 |
| Sandoz Inc | 3 | tablet | Generic drugs (ANDA) | December 19, 2003 |
| Unichem Pharmaceuticals (USA), Inc. | 3 | tablet | Generic drugs (ANDA) | March 30, 2021 |
| Actavis Pharma, Inc. | 2 | tablet | Generic drugs (ANDA) | August 1, 1992 |
| Actavis Pharma, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | January 2, 2007 |
| Ajanta Pharma USA Inc. | 2 | tablet | Generic drugs (ANDA) | May 20, 2021 |
| Amneal Pharmaceuticals LLC | 2 | tablet | Generic drugs (ANDA) | July 1, 2019 |
| Ani Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | October 25, 2021 |
| Ani Pharmaceuticals, Inc. | 2 | tablet, film coated | Generic drugs (ANDA) | April 24, 2017 |
| Aphena Pharma Solutions - Tennessee, LLC | 2 | tablet | Generic drugs (ANDA) | October 19, 2004 |
| Ascend Laboratories, LLC | 2 | tablet | Generic drugs (ANDA) | February 13, 2020 |
| Azurity Pharmaceuticals, Inc. | 2 | tablet | New drug applications (NDA) | February 1, 2013 |
| Chartwell RX, LLC | 2 | tablet | Generic drugs (ANDA) | February 26, 2019 |
| Coupler LLC | 2 | tablet | Generic drugs (ANDA) | January 28, 2025 |
| Ipca Laboratories Limited | 2 | tablet | Generic drugs (ANDA) | September 21, 2026 |
| Jubilant Cadista Pharmaceuticals Inc. | 2 | tablet | Generic drugs (ANDA) | March 31, 2021 |
| Lifestar Pharma LLC | 2 | tablet | Generic drugs (ANDA) | August 5, 2022 |
| Macleods Pharmaceuticals Limited | 2 | tablet | Generic drugs (ANDA) | July 1, 2026 |
| Nivagen Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | May 28, 2018 |
| PD-Rx Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | August 1, 1992 |
| PD-Rx Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | October 27, 2023 |
| Rising Pharma Holdings, Inc. | 2 | tablet | Generic drugs (ANDA) | June 22, 2023 |
| Sun Pharmaceutical Industries, Inc. | 2 | tablet | Generic drugs (ANDA) | February 12, 2016 |
| Tagi Pharma, Inc. | 2 | tablet | Generic drugs (ANDA) | August 5, 2022 |
| Umedica Laboratories USA Inc. | 2 | tablet | Generic drugs (ANDA) | February 15, 2026 |
| Zydus Pharmaceuticals USA Inc. | 2 | tablet | Generic drugs (ANDA) | March 12, 2019 |
| Zydus Pharmaceuticals USA Inc. | 2 | tablet | Generic drugs (ANDA) | May 15, 2019 |
| AvPAK | 1 | tablet | Generic drugs (ANDA) | November 12, 2019 |
| Casper Pharma LLC | 1 | tablet | New drug applications (NDA) | November 27, 2019 |
| Proficient Rx LP | 1 | tablet | Generic drugs (ANDA) | February 13, 2020 |
| Proficient Rx LP | 1 | tablet | Generic drugs (ANDA) | May 28, 2018 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 191 | 92.7% |
| Tablet, film coated | 15 | 7.3% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.